FdaApplication

NDA 020950

Back to search

Identifiers

Properties

PropertyValue
applicant_namePHARMOBEDIENT CONSULTING LLC
application_typeNDA
approval_date2001-03-21

Products (1)

ProductActive ingredientStrengthDosage form
DUONEBALBUTEROL SULFATE; IPRATROPIUM BROMIDEEQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION;INHALATION

1 product